-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
One man, his dog, and ChatGPT: Australia's AI vaccine saga
Desperate to help his sick dog, one Australian man went down the ultimate ChatGPT research hole, using artificial intelligence to design a personalised experimental treatment and finding top scientists to administer it.
Paul Conyngham's months-long quest to fight his rescue mutt Rosie's cancer has grabbed the attention of OpenAI boss Sam Altman, who called it an "amazing story" in an X post on Friday.
Sydney-based AI consultant Conyngham told AFP that eight-year-old Rosie's mast cell cancer is now in partial remission and her biggest tumour has shrunk dramatically.
"She regained a lot of mobility and function" after receiving a custom mRNA vaccine along with powerful immunotherapy in December, he said.
Conyngham does not call his findings a cure -- but experts unrelated to the dogged endeavours said they highlight AI's potential to accelerate medical research.
"I would have conversations and just keep them going non-stop" with ChatGPT, Gemini and Grok to study cancer therapies in-depth, Conyngham said.
Following the chatbots' advice, he paid $3,000 to have Rosie's genome sequenced, and used the same online tools to analyse her DNA data.
Next he turned to AlphaFold, a scientific AI model that won 2024's chemistry Nobel, to better understand one of the mutated doggy genes.
Conyngham sought the help of a University of New South Wales (UNSW) team -- also thanks to a ChatGPT recommendation -- and other academics in Australia who made his research a reality.
- 'Just a rash' -
Rosie's cancer was misdiagnosed for nearly a year, Conyngham said on the phone during one of the long daily walks the pair have resumed.
"I took her to the vet three times. And two times, the vet said, don't worry about it, it's just a rash," he said.
But Rosie got sicker and a biopsy showed in 2024 that she did have terminal cancer.
Having tried chemotherapy, standard immunotherapy and surgery, costs were mounting and Conyngham wanted more options.
So he used AI to delve deep into the world of emerging treatments including mRNA vaccines, which train the body's immune system and were widely used during the Covid pandemic.
"This was not a clinical trial by any means" and "it's not that AI cured cancer", said UNSW professor Martin Smith, who sequenced Rosie's genome for Paul.
"It was really driven by his determination to help his dog."
The combination of "three different disruptive technologies: genome sequencing, artificial intelligence, and RNA therapeutics... offers new possibilities and challenges", Smith said.
- AI promise -
Chatbots also assisted Conyngham in navigating the reams of paperwork for ethical approval.
And through his new scientific network, he met a professor at the University of Queensland able to administer the fine-tuned treatment.
Not all the tumours responded as well as the largest one, however. Rosie has had to have another operation since, and it's unclear how long she has left to live.
The "short answer is we don't know for sure" what actually led to the reduction in size of Rosie's biggest tumour, said Pall Thordarson, director of UNSW's RNA institute which created the vaccine.
"He used the AI program... to design the actual mRNA sequence. And then he gave that information to us," Thordarson explained.
"AI holds lots of promise to improve and accelerate our research strategies," Nick Semenkovich at the Medical College of Wisconsin, unrelated to the Rosie saga, told AFP.
But UNSW and Conyngham "haven't published scientific details outside of their press release and interviews, so we don't know enough about the vaccine to understand how much AI helped in its development -- or if the vaccine worked the way it was designed", Semenkovich said.
Patrick Tang Ming-kuen, a professor from The Chinese University of Hong Kong, said AI-powered research could help pets and humans survive, although the risk of errors is real.
"AI transforms a 'needle-in-a-haystack' search into a data-driven selection process, drastically shortening the timeframe between diagnosis and vaccine construction," he said.
Since Conyngham's story went global, Smith said his team have been fielding various new requests.
"You know: my cat's got a disease, my dog's got a disease, my aunt has got a disease."
But "it's hard for us to be able to help", he said. "There's a lot of things that have to align."
W.Stewart--AT